retatrutide phase 2 weight loss trial results Looking forward to when # retatrutide's 3 will become available Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon

At the starting dose of 0.25mg per week, a 10mg vial contains 40 weekly doses

Because retatrutide is not currently licensed in the UK, the most important safety message is straightforward: this medication should not be self-administered outside of an approved clinical trial or a formal MHRA access scheme (such as the Early Access to Medicines Scheme [EAMS] or named-patient unlicensed supply) overseen by a qualified medical team

varies widely) Total Monthly Cost Examples : Zepbound vials + membership: $494-$644/month Wegovy cash-pay + membership: $644/month Insurance-covered + membership: $170-$445/month (highly variable) All pricing subject to change

These medications can be an attractive weight loss tool, especially if youve just had a baby